Skip to main content
. 2017 Nov 13;189(45):E1386–E1395. doi: 10.1503/cmaj.170527

Table 1:

Recent guideline recommendations for management of acute nonspecific low-back pain

Type Intervention Size of effect* Quality of evidence* Endorsement
2016 UK guideline14 2017 US guideline15
Nonpharmacologic Advice to stay active v. bed rest Small Moderate (2 RCTs)35 Yes Yes
Massage v. sham treatment Moderate Low (2 RCTs) Yes, if part of an exercise program Yes
Spinal manipulation v. inert treatment No effect Low (3 RCTs) Yes, if part of an exercise program Yes
Acupuncture v. sham treatment Small Low (3 RCTs) Do not offer Yes
Heat v. sham treatment Moderate Moderate (4 RCTs) No mention Yes
Exercise v. usual care No effect Low (6 RCTs) Yes No mention
Psychologically informed physiotherapy v. usual care No trials N/A Yes, for those at high risk of poor outcome No mention
Pharmacologic NSAIDs v. placebo Small Moderate (5 RCTs) Yes Yes, depending on patient preferences and drug risk profile
Muscle relaxants v. placebo Small Moderate (5 RCTs) No mention Yes, depending on patient preferences and drug risk profile
Opioids v. placebo No trials N/A Yes, if NSAIDs are unsafe or ineffective; weak opioid only Do not offer
Paracetamol v. placebo No effect High (2 RCTs)36 Do not offer Do not offer
Systemic corticosteroids v. placebo No effect Low (2 RCTs) No mention Do not offer

Note: GRADE = Grading of Recommendations Assessment, Development and Evaluation, N/A = No evidence from RCTs, NSAID = nonsteroidal anti-inflammatory drug, RCT = randomized controlled trial.

*

Based on 2017 American College of Physicians guideline summary of evidence except where otherwise noted. Comparisons are to placebo, sham treatment, no treatment or usual care, and on short-term pain outcomes.

Our summary of evidence used the GRADE approach.